KaloCyte has demonstrated proof of concept for ErythroMer, a dried, bio-inspired artificial red blood cell envisioned for use when stored red blood cells are unavailable, undesirable or in short supply. Supported by nearly $6M in federal awards and investor funding, KaloCyte was founded by a distinguished team of researchers in physiology, bioengineering, and trauma care, with support from the BioGenerator Fundamentals program in St. Louis, Missouri.
President and CEO
670 W. Baltimore St.
Baltimore Maryland 21201United States